ScholarIQanswers from OpenAlex & ORCID
Milena Vraná
ResearcherPublications, citations & collaboration network
Milena Vraná is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Milena Vraná have?
ScholarIQindexed works
Milena Vraná has 38 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Milena Vraná have?
ScholarIQcitation count
Milena Vraná has 152 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Milena Vraná?
ScholarIQh-index
Milena Vraná has an h-index of 6 in OpenAlex.
What is the i10-index of Milena Vraná?
ScholarIQi10-index
Milena Vraná has an i10-index of 3 in OpenAlex.
What is the ORCID of Milena Vraná?
ScholarIQorcid
The ORCID for Milena Vraná is on the source record.
What is the OpenAlex record for Milena Vraná?
ScholarIQopenalex
The OpenAlex for Milena Vraná is on the source record.
What are the most-cited papers on Milena Vraná?
ScholarIQmost cited works
Impact of <i>HLA‐DPB1</i> allelic and single amino acid mismatches on HSCT
Katarina Ludajic, Yesilda Balavarca, Heike Bickeböller, David Pohlreich, Michal Kouba, Marie Dobrovolná, Milena Vraná, Agathe Rosenmayr, Gottfried Fischer, Ingrid Faé, Peter Kalhs, Hildegard Greinix
Association of HLA class I type with prevalence and outcome of patients with acute myeloid leukemia and mutated nucleophosmin
Kateřina Kuželová, Barbora Brodská, Johannes Schetelig, Christoph Röllig, Zdeněk Ráčil, Juliane S. Walz, Grzegorz Helbig, Ota Fuchs, Milena Vraná, Pavla Pecherková, Cyril Šálek, Jiřı́ Mayer
Cytotoxic T lymphocyte precursor frequency analysis in the selection of HLA matched unrelated donors for hematopoietic stem cell transplantation: the correlation of CTLp frequency with HLA class I genotyping and aGVHD development.
L Doležalová, Milena Vraná, Marie Dobrovolná, M Loudová, Cukrová, Antonı́n Vı́tek, J Sajdová, Jan Starý, P Sedlácek
Characteristics of fever produced by Hypersensitivity Pyrogen
J Johanovský, Milena Vraná, A Stejskal
Allo-SCT in children with high-risk leukemia using unmanipulated grafts from alternative donors
Petr Sedláček, Ester Mejstříková, Renata Formánková, Petra Keslová, Marie Dobrovolná, Milena Vraná, Jan Starý